ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996

In Brief: Alice Fordyce, Supporter of Medical Research, Dead At 86; Broder Awarded Block Lectureship

September 18, 1992

Spotlight Article TCL Archive

Breast Cancer Report To The Profession Suddenly Is a Report To The Nation; Treatment Progress Noted

October 4, 1974

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007